We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

25 hedge funds and large institutions have $18.6M invested in Minerva Neurosciences in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

148% more capital invested

Capital invested by funds: $7.51M → $18.6M (+$11.1M)

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

9% more funds holding

Funds holding: 23 → 25 (+2)

4.51% less ownership

Funds ownership: 42.5% → 38% (-4.5%)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

57% less call options, than puts

Call options by funds: $217K | Put options by funds: $510K

Holders
25
Holders Change
+2
Holders Change %
+8.7%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
6
Closed
5
Calls
$217K
Puts
$510K
Net Calls
-$293K
Net Calls Change
-$415K

Top Buyers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
+$1.48M
2
Renaissance Technologies
Renaissance Technologies
New York
+$392K
3
BlackRock
BlackRock
New York
+$164K
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$148K
5
Truist Financial
Truist Financial
North Carolina
+$65.4K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$1.95M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.13M
3
Millennium Management
Millennium Management
New York
-$303K
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$129K
5
SEI Investments
SEI Investments
Pennsylvania
-$126K
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$11.1M – – –
AG
2
Artal Group
Luxembourg
$2.31M +$1.48M +250,000 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.51M -$1.95M -328,483 -67%
Renaissance Technologies
4
Renaissance Technologies
New York
$940K +$392K +66,189 +186%
BlackRock
5
BlackRock
New York
$721K +$164K +27,612 +55%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$367K – – –
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$274K -$1.13M -191,350 -87%
Millennium Management
8
Millennium Management
New York
$264K -$303K -51,076 -64%
Fidelity Investments
9
Fidelity Investments
Massachusetts
$261K -$129K -21,855 -44%
Point72 Asset Management
10
Point72 Asset Management
Connecticut
$231K +$148K +25,000 New
BCM
11
Bridgeway Capital Management
Texas
$149K – – –
State Street
12
State Street
Massachusetts
$127K – – –
Morgan Stanley
13
Morgan Stanley
New York
$126K +$39.3K +6,627 +95%
Truist Financial
14
Truist Financial
North Carolina
$102K +$65.4K +11,043 New
Group One Trading
15
Group One Trading
Illinois
$54K -$213 -36 -0.6%
UBS Group
16
UBS Group
Switzerland
$53K +$30.6K +5,167 +915%
Lazard Asset Management
17
Lazard Asset Management
New York
$19K +$12.3K +2,084 New
Wells Fargo
18
Wells Fargo
California
$18K -$1.16K -196 -9%
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$11K +$7K +1,181 New
Russell Investments Group
20
Russell Investments Group
United Kingdom
$10K – – –
TFM
21
TFC Financial Management
Massachusetts
$2K – – –
Northwestern Mutual Wealth Management
22
Northwestern Mutual Wealth Management
Wisconsin
$1K +$592 +100 New
AIM
23
Anchor Investment Management
South Carolina
$111 – – –
Bank of Montreal
24
Bank of Montreal
Ontario, Canada
$97 +$59.2K +10,000 New
SEI Investments
25
SEI Investments
Pennsylvania
– -$126K -37,998 Closed
1
2

NERV Hedge Fund Activity: Q3 2022 in Review

25 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q3 2022, worth a combined $18.6M — up 148% from $7.51M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new NERV positions and 5 closed out — a net gain of 2 holders — while 4 added to existing stakes and 6 trimmed.

The largest buyer was Artal Group, opening a new position worth an estimated $1.48M. The largest seller was Vanguard Group, cutting an estimated $1.95M.

  • 25 institutional investors held Minerva Neurosciences (NERV) as of Q3 2022, up from 23 in Q2 2022.
  • Funds reported $18.6M of Minerva Neurosciences stock for Q3 2022, up 148% quarter-over-quarter.
  • 7 funds opened new Minerva Neurosciences positions in Q3 2022 and 5 closed out, a net change of +2 holders.
  • The largest Minerva Neurosciences buyer in Q3 2022 was Artal Group, an estimated $1.48M added.
  • The largest Minerva Neurosciences seller in Q3 2022 was Vanguard Group, an estimated $1.95M sold.

Based on aggregated 13F filings for Q3 2022.